Position in NAMS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$37,373,383
+$10,580,853 QoQ
Shares Held
1,102,785
+31.8% QoQ
Ownership
0.923%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#24
of 198 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aberdeen Group plc holds $1,997,986,618 across 85 Biotechnology names. NAMS ranks #13 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MANE |
Veradermics, Inc
|
1,096,642 | $134,821,167 | |
| 2 | QURE |
uniQure N.V.
|
2,848,117 | $131,184,269 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,601 | $104,611,833 | |
| 4 | ARGX |
Argenx SE
|
83,822 | $77,767,536 | |
| 5 | ABVX |
Abivax S.A.
|
522,025 | $69,565,051 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
101,566 | $63,330,462 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
646,943 | $61,569,565 | |
| 8 | INSM |
INSMED Inc
|
577,437 | $61,566,331 |
All Filings in NAMS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,373,383 | 1,102,785 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $26,792,530 | 837,005 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $25,590,298 | 729,484 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $18,825,744 | 661,946 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $13,311,429 | 735,032 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $7,714,385 | 376,863 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,601,842 | 179,060 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $2,142,396 | 129,060 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $1,459,960 | 76,000 | Shares | Defined | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||